{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:46:35Z","timestamp":1789443995558,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.ijrobp.2004.12.033","type":"journal-article","created":{"date-parts":[[2005,3,15]],"date-time":"2005-03-15T12:21:40Z","timestamp":1110889300000},"page":"1363-1370","source":"Crossref","is-referenced-by-count":67,"title":["Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer"],"prefix":"10.1016","volume":"62","author":[{"given":"Matthew S.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Minsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Saltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyn","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Chessin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Guillem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2004.12.033_bib1","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.282.24.2340","article-title":"Effect of statins on risk of coronary disease","volume":"282","author":"LaRosa","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib2","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib3","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib4","first-page":"1055","article-title":"Potential antitumor effects of statins","volume":"23","author":"Jakobisiak","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib5","first-page":"2223","article-title":"Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells","volume":"5","author":"Agarwal","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib6","first-page":"632","article-title":"Evidence for deficiency of low density lipoprotein receptor on human colonic carcinoma cell lines","volume":"50","author":"Fabricant","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib7","first-page":"879","article-title":"Synergistic interaction between highly specific cyclooxygenase-2 inhibitor, MF-tricyclic and lovastatin in murine colorectal cancer cell lines","volume":"9","author":"Feleszko","year":"2002","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1023\/A:1006548902592","article-title":"Low density lipoproteins and lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro","volume":"16","author":"Mehta","year":"1998","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib9","first-page":"1S","article-title":"HMG CoA reductase inhibitors and the risk of colorectal cancer","volume":"22","author":"Poynter","year":"2004","journal-title":"Proc ASCO"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib10","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.1016\/S0360-3016(03)01114-3","article-title":"Statin use is associated with improved biochemical outcome after high dose radiotherapy for clinically localized prostate cancer","volume":"57","author":"Katz","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1054\/bjoc.2000.1716","article-title":"Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial","volume":"84","author":"Kawata","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib12","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM198506063122301","article-title":"Prolongation of the disease-free interval in surgically treated rectal carcinoma","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib13","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1056\/NEJM198611133152014","article-title":"Survival after postoperative combination treatment of rectal cancer","volume":"315","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/bjs.1800840827","article-title":"Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group","volume":"84","author":"Tveit","year":"1997","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib15","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00000421-200104000-00001","article-title":"Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer","volume":"24","author":"Janjan","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s10350-004-6545-x","article-title":"A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision","volume":"46","author":"Garcia-Aguilar","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000658-200207000-00012","article-title":"Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy","volume":"236","author":"Ruo","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10350-004-6325-7","article-title":"T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival","volume":"45","author":"Theodoropoulos","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2003.07.125","article-title":"Impact of diabetes mellitus on outcomes in patients with colon cancer","volume":"21","author":"Meyerhardt","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0360-3016(00)01529-7","article-title":"Preoperative combined modality therapy for clinically respectable UT3 rectal adenocarcinoma","volume":"49","author":"Grann","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1053-4296(05)80076-1","article-title":"Pelvic radiation therapy in rectal cancer","volume":"3","author":"Minsky","year":"1993","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib23","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archsurg.133.8.894","article-title":"Rectal cancer","volume":"133","author":"Heald","year":"1998","journal-title":"Arch Surg"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib24","first-page":"335","article-title":"Total mesorectal excision in the operative treatment of carcinoma of the rectum","volume":"181","author":"Enker","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1072-7515(01)01159-0","article-title":"Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer","volume":"194","author":"Hiotis","year":"2002","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib26","series-title":"Categorical data analysis","author":"Agresti","year":"1990"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib27","first-page":"690","article-title":"Chi-square tests with one degree of freedom","volume":"58","author":"Mantel","year":"1963","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib28","series-title":"Statistical methods in cancer research, volume I","author":"Breslow","year":"1980"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib29","series-title":"Applied logistic regression","author":"Hosmer","year":"2000"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents","volume":"94","author":"Thun","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2003.12.006","article-title":"Sphincter preservation following preoperative radiotherapy for rectal cancer","volume":"72","author":"Bujko","year":"2004","journal-title":"Radiother Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijrobp.2004.12.033_bib32","first-page":"S178","article-title":"Induction oxaliplatin + 5-FU improves further the incidence of pT0 downstaged surgical specimens in \u2265cT3 rectal cancer treated with preoperative chemoradiation","volume":"57","author":"Calvo","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib33","first-page":"253S","article-title":"Randomized phase II trial of preoperative combined modality chemoradiation for distal rectal cancer","volume":"22","author":"Mitchell","year":"2004","journal-title":"Proc ASCO"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00000421-198512000-00012","article-title":"Activated human N-ras oncogene enhances x-irradiation repair of mammalian cells in vitro less effectively at low dose rate. Implications for increased therapeutic ratio of low dose rate irradiation","volume":"8","author":"FitzGerald","year":"1985","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.3277276","article-title":"The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation","volume":"239","author":"Sklar","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib37","first-page":"1754","article-title":"Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes","volume":"58","author":"Bernhard","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib38","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/annonc\/mdf173","article-title":"A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan","volume":"13","author":"Sharma","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib39","doi-asserted-by":"crossref","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","article-title":"Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase","volume":"273","author":"Laufs","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2003.08.035","article-title":"Rho GTPases","volume":"206","author":"Aznar","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib41","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","article-title":"The risk of cancer in users of statins","volume":"22","author":"Graaf","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib42","first-page":"927","article-title":"Prognostic value of low density lipoprotein receptor expression in colorectal carcinoma","volume":"5","author":"Caruso","year":"1998","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib43","first-page":"451","article-title":"Enhanced 3-hydroxy-3-methyl-glutaryl coenzyme A reductase activity in human colorectal cancer not expressing low density lipoprotein receptor","volume":"19","author":"Caruso","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","article-title":"Barriers to drug delivery in solid tumors","volume":"271","author":"Jain","year":"1994","journal-title":"Sci Am"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib45","first-page":"483","article-title":"Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer","volume":"2","author":"Thibault","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1006481423298","article-title":"Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma","volume":"19","author":"Kim","year":"2001","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ijrobp.2004.12.033_bib47","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000421-199812000-00010","article-title":"A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme","volume":"21","author":"Larner","year":"1998","journal-title":"Am J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604031505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604031505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T02:58:53Z","timestamp":1548644333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301604031505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0360301604031505"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2004.12.033","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}